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Background: Aortic valve replacement (AVR) with a small aortic annulus is always challenging for the cardiac
surgeon. In this study, we sought to evaluate the midterm performance of implantation with a 17-mm or 19-mm
St. Jude Medical Regent (SJM Regent) mechanical valve in retrospective consecutive cohort of patients with small
aortic annulus (diameter≤ 19 mm).
Methods: From January 2008 to April 2011, 40 patients (31 female, mean age = 47.2 ± 5.8 years) with small aortic
annulus (≤19 mm in diameter) underwent aortic valve replacement with a 17-mm or 19-mm St. Jude Medical
Regent (SJM Regent) mechanical valve. Preoperative mean body surface area, New York Heart Association class, and
mean aortic annulus were 1.61 ± 0.26 m2, 3.2 ± 0.4, and 18 ± 1.4 mm respectively. Patients were divided into two
groups, according to the implantation of 17 mm SJM Regent mechanical valve (group 1, n = 18) or 19 mm SJM
Regent valve (group 2, n = 22). All patients underwent echocardiography examination preoperatively and at one
year post-operation.
Results: There were no early deaths in either group. Follow-up time averaged 36 ± 17.6 months. The mean
postoperative New York Heart Association class was 1.3 ± 0.6 (p < 0.001). By echocardiography, in group 1, the left
ventricular ejection fraction (LVEF), left ventricular fraction shortening (LVFS), and the indexed effective orifice area
(EOAI) increased from 43.7%± 11.6%, 27.3%± 7.6%, and 0.70 ± 0.06 cm2/m2 to 69.8 ± 9.3%, 41.4 ± 8.3%, and
0.92 ± 0.10 cm2/m2 respectively (P< 0.05), while the left ventricular mass index (LVMI), and the aortic transvalvular
pressure gradient decreased from 116.4 ± 25.4 g/m2, 46.1 ± 8.5 mmHg to 86.7 ± 18.2 g/m2 , 13.7 ± 5.2 mmHg
respectively. In group 2, the LVEF, LVFS and EOAI increased from 45.9%± 9.7%, 30.7% ± 8.0%, and 0.81 ± 0.09 cm2/m2
to 77.4%± 9.7%, 44.5%± 9.6%, and 1.27 ± 0.11 cm2/m2 respectively, while the LVMI, and the aortic transvalvular
pressure gradient decreased from 118.3 ± 27.6 g/m2, 44.0 ± 6.7 mmHg to 80.1 ± 19.7 g/m2, 10.8 ± 4.1 mmHg as well.
The prevalence of PPM was documented in 2 patients in Group 1.
Conclusions: Patients with small aortic annulus and body surface area, experienced satisfactory clinical
improvement after aortic valve replacement with modern SJM Regent bileaflet prostheses.
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Aortic valve replacement (AVR) with a small aortic annu-
lus is always challenging for the cardiac surgeon. Trad-
itional small mechanical valves, especially if implanted in
patients with big body surface area, may show high aortic
transvalvular pressure gradients, the so-called patient–
prosthesis mismatch (PPM) phenomenon [1]. Several
surgical strategies can be applied to avoid PPM, among
them aortic root enlargement procedure seems a pre-
ventive potential strategy to minimize mismatch, since it
showed good early and long-term results in experienced
centers [2]. However, this approach is complex and time-
consuming that may cause serious bleeding and infec-
tion, and can be difficult to perform in patients with a
small, calcified aortic annulus and root.
On the other hand, modern St.Jude Medical Regent (SJM
Regent) mechanical valve is much more favored for the
unique design and the bigger effective orifice area (EOA). By
shifting the sewing cuff and the retaining ring to the supra-
annular position, the SJM Regent valve achieve a greater
geometric orifice for a fixed diameter, which may prevent
PPM phenomenon in patients with small aortic annulus as
well [3-5]. In our present study, we sought to review the
midterm performance of implantation with a 17-mm or 19-
mm SJM Regent mechanical valve in consecutive patients
with small aortic annulus (diameter≤19 mm), and evaluate
whether it is a preventive strategy to eliminate PPM.
Methods
Patients
From January 2008 to April 2011, 1946 AVR procedures
with mechanical prostheses were performed in our hos-
pital. A 17-mm or a 19-mm SJM Regent was implanted in
54 (2.8%) patients. Of those 54 patients, 14 patients were
excluded because of the big aortic annulus (>19 mm in
diameter); thus, only 40 patients entered the study. Those
40 patients (31 female versus 9 male) with small aortic an-
nulus (≤19 mm in diameter) underwent aortic valve re-
placement with a 17-mm or 19-mm St. Jude Medical
Regent (SJM Regent) mechanical valve. The mean age was
47.2± 5.8 years (ranging from 17 to 69 years), and the
body surface area was 1.61± 0.26 m2 (ranging from 1.51
to 1.77 m2). Preoperative average New York Heart Associ-
ation class was 3.2 ± 0.4 with 32 patients of grade III and 8
patients of grade IV. Aortic valve characteristics were
summarized in Table 1. Patients were divided into two
groups, according to the implantation of 17 mm SJM Re-
gent mechanical valve (group 1, n = 18) or 19 mm SJM Re-
gent valve (group 2, n = 22). The calculation formulae of
body surface area (BSA) were:Male : S ¼ 0:0057 height cmð Þ þ 0:0121 weight kgð Þ
Female : S ¼ 0:0073 height cmð Þ þ 0:0127 weight kðThe surgical procedures were performed through a
midline sternotomy under cardiopulmonary bypass and
mild hypothermia. Myocardial protection was achieved
with cold blood cardioplegia perfusion into coronary ar-
teries or the aortic root, and the surface of heart was
covered with ice. Valve prostheses were implanted at the
valve ring level with non-everting interrupted mattress
sutures. After the second postoperative day, patients
received oral anticoagulation with sodium warfarin at
daily updated dosages according to international normal-
ized ratios. The target international normalized ratio
value was in accordance with American Heart Associ-
ation guidelines.Echocardiography
A complete M-mode, two-dimensional, and Doppler
evaluation was performed at the probe frequency of
2.5/2.7 MHZ using commercially available ultrasono-
graphic equipment (HP Sonos5500) in Zhongshan Hos-
pital, Fudan University. Left ventricular (LV) end-diastolic
and end-systolic diameters and volumes, as well as left
ventricular ejection fraction (LVEF), left ventricular frac-
tion shortening (LVFS), were calculated using the area-
length method. Left ventricular mass index (LVMI) was
calculated from Reichek’s formula. As regard to aortic
valve evaluation, we measured indexed aortic valve area
(EOAI), aortic annulus diameter, and the aortic transvalv-
ular pressure gradient. Echocardiographic evaluation with
the same variables was repeated at follow-up.Follow-ups
All patients were followed in the outpatient center
with clinical visits and echocardiography performed on
a 6-month basis. A telephone interview was required only
for patients with follow-up visits in excess of 6 months or
for those lost to ambulatory follow-up. The follow-up was
100% complete, and the mean time to last follow-up was
36± 17.6 months (ranging from 12 to 51 months).Statistics
Statistics were calculated using stata 7.0. The continuous
varieties were expressed as average ± standard deviation,
the Wilcoxon method was used to test the difference be-
tween two continuous varieties, and t-test was used to
test paired samples. P < 0.05 means there is statistical dif-
ferences, and P < 0.01 represents significant statistical
differences.þ 0:0882;
gÞ  0:2106:
Table 1 Aortic valve characteristics
Group 1 (17 mm Regent, n = 18) Group 2 (19 mm Regent, n = 22) P value
Aortic stenosis (congenital) 2 (11.1%) 3 (13.6%) NS
Aortic stenosis (degenerative) 4 (22.2%) 3 (13.6%) NS
Aortic insufficiency (rheumatic) 8 (44.4%) 10 (45.5%) NS
Aortic stenosis and insufficiency (rheumatic) 3 (16.7%) 4 (18.2%) NS
SBE 1 (5.6%) 2 (9.1%) NS
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Clinical results and follow-up
Operative details were shown in Table 2. An AVR pro-
cedure was performed in all 40 patients. Concomitant
performed procedures included MV surgery, TV surgery,
and CABG, and there were no difference between the
two groups. Mean crossclamp time was similar between
treatment groups (1 vs 2) (45 ± 6 minutes vs 51 ± 4 min-
utes; P= .6), as was total bypass time (78 ± 6 minutes vs
81 ± 7 minutes; P = .54).
There were no early deaths in either group. One early
nonfatal cerebrovascular accident was observed in group
2. No severe arrhythmia, low cardiac output syndrome,
pericardial tamponade, respiratory failure, hepatic failure
and renal failure were observed. Follow-up time averaged
36± 17.6 months. The mean postoperative New York
Heart Association class was 1.3 ± 0.6 (p < 0.001), and no
further 1-year mortality occurred.Evaluation of heart function
All patients underwent echocardiography examination
preoperatively and at one year post-operation.
As shown in Table 3, the left cardiac functions of
the patients replaced with Regent valve were improved
at one year after the operation as compared to pre-
operation. By echocardiography, in group 1, the LVEF
and LVFS increased from 43.7%± 11.6%, 27.3%± 7.6%
pre-operatively to 69.8 ± 9.3%, 41.4± 8.3% after oper-
ation, respectively (P< 0.01). In group 2, the LVEF and
LVFS increased from 45.9%±9.7%, 30.7%±8.0%, and to
77.4%± 9.7%, 44.5%±9.6% as well (P< 0.01). There was
no significant difference between two groups.
In both groups, left ventricular mass regression occurred.
In group 1, LVMI decreased from 116.4±25.4 g/m2 pre-
operatively to 86.7± 18.2 g/m2 at follow-up (P<0.05), whileTable 2 Concomitant operative characteristics
Group 1 (17 mm Regent, n = 18)
MV surgery 8 (44%)
TV surgery 6 (33%)
CABG 2 (11%)
Total bypass time 78± 6 minutes
Crossclamp time 45± 6 minutesin group 2, it decreased from118.3± 27.6 g/m2 pre-
operatively to 80.1±19.7 g/m2 at follow-up (P<0.05).
Using a 17-mm or 19-mm SJM Regent, also shown in
Table 3 in both groups, hemodynamic performance
improved as well. In group 1, aortic transvalvular pres-
sure gradient decreased from 46.1 ± 8.5 mmHg to
13.7 ± 5.2 mmHg (P < 0.01).In group 2, aortic transvalvu-
lar pressure gradient decreased from 44.0 ± 6.7 mmHg to
10.8 ± 4.1 mmHg (P < 0.01). The hemodynamic perfor-
mances in the two groups showed no significant differ-
ence (13.7 ± 5.2 mmHg versus 10.8 ± 4.1 mmHg).
On the other hand, though EOAI increased in both
groups at one-year follow-up as compared to pre-operation,
a 19-mm SJM Regent showed superior EOAI as com-
pared to that in group 1(1.27 ± 0.11 cm2/m2 versus
0.92 ± 0.10 cm2/m2, P < 0.01).
Prothesis-Patient Mismatch
The prevalence of PPM, defined as an indexed effective
orifice area (EOA) of less than 0.85 cm2/m2, was docu-
mented in 2 patients (11%, the EOA of the one patient
was 0.77 cm2/m2, the other was 0.83 cm2/m2) in group
1, and 0 in group 2. These two patients were both male
with larger body surface area. However, the presence of
PPM did not affect early and mid-term survival or post-
operative functional status. A significant reduction of
aortic transvalvular pressure gradient occurred in both
patients.
Discussion
PPM, a concept widely accepted by many scholars
[1,6-16], refers to a series of complications or potential
risks that occurred when the size of a implanted valve
prosthesis mismatches the patients’ BSA. Several surgical




81 ± 7 minutes NS
51 ± 4 minutes NS
Table 3 Comparison of cardiac function in two groups
LVEF(%) LVSF(%) LVMI(g/m2) Gradient EOAI
(mmHg) (cm2/m2)
Group 1 Pre 43.7 ± 11.6 27.3 ± 7.6 116.4 ± 25.4 46.1 ± 8.5 0.70 ± 0.06
Post 69.8 ± 9.3* 41.4 ± 8.3* 86.7 ± 18.2# 13.7 ± 5.2* 0.92 ± 0.10#
Group 2 Pre 45.9 ± 9.7 30.7 ± 8.0 118.3 ± 27.6 44.0 ± 6.7 0.81 ± 0.09
Post 77.4 ± 9.7* 44.5 ± 9.6* 80.1 ± 19.7# 10.8 ± 4.1* 1.27 ± 0.11#$
Pre: pre-operation; Post: one year post-operation; # P < 0.05 , * P < 0.01 as compared to pre-operation, $ P < 0.01, as compared to group 1 post-operation.
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potential strategy to minimize mismatch. However, this
approach is complex and time-consuming that may cause
serious bleeding and infection, and can be difficult to
perform in patients with a small, calcified aortic annulus
and root. In the present study, we applied modern SJM
Regent valves in patients with small aortic annulus, and
sought to evaluate whether SJM Regent valve could be an
alternate choice to minimize PPM.
It is no doubt that PPM has a significant negative im-
pact on the regression of left ventricular hypertrophy,
the improvement of left cardiac function, and a long life
survival, as Castro point out [2]. To minimize PPM after
AVR, we need to understand the most determinant fac-
tors of PPM. In 1997, Sawant pointed out BSA≥ 1.9 m2
as a risk factor for patients replaced with small mechan-
ical valve (outer diameter < 21 mm), and may lead to
sudden death [17]. Later in 2000, Pibarot [6] held the
view that whether there will be PPM after operation
depends on BSA, as well as effective orifice area of the
valve prosthesis. More recently, Botzenhardt [18] found
out that the ratio of EOA of the valve to BSA (EOAI) is
an indicator which is more important than the aortic
transvalvular pressure gradient. As they concluded, when
EOAI > 0.85 cm2/m2, no PPM is presented; when the
EOAI is between 0.65-0.85 cm2/m2, a moderate PPM
can be seen; and if the EOAI is lower than 0.65 cm2/m2,
the PPM can be severe [6,18]. From this view, given that
the BSA of the patient is stable, to minimize PPM after
AVR, we need to increase the EOA of the implanted
valve.
Nowadays, there are three strategies to increase the
EOA of the implanted valve when treating patients with
small aortic annulus [19]: (1) aortic annulus enlarge-
ment; (2) stentless bioprothesis valve; (3) mechanical
valve of same diameter with bigger EOA, including SJM
Regent mechanical valve, Carbomedics Top-hat valve,
Sorin Slimline valve, and ATS AP valve. Although annu-
lus/root enlargement procedures, as well as stentless
valve implantation, performed in experienced centers,
showed good early and long-term results [2,20], these
two procedures were complex and time-consuming. By
shifting the sewing cuff and the retaining ring to the
supra-annular position, the SJM Regent possesses alarger EOA. In our present study, most (38/40) patients
got a satisfactory heart function improvement and life
quality after implantation of a 17 mm or 19 mm Regent
valve with two patients of PPM. The good results are
persistent with the superior dynamic aspects of Regent
valve as others showed. Kon’s research on Regent valve
revealed that the blood flows through the valve is lam-
inar, the transvalvular pressure gradient is low, and the
EOA and EOAI are satisfying [21]. The report showed
that the mean/peak aortic transvalvular pressure gradient
were 3/7 mmHg for healthy people at rest and 4/9 mmHg
in motion, and the application of Regent valve could meet
the standard [17]. Due to the aspect of hemodynamics,
Okumiya hold the view that the cardiac indexes of
patients replaced with SJM Regent mechanical valve are
far more better than those of the patients replaced with
conventional mechanical valves [22].
In our present study, using 17 mm or 19 mm Regent
valve as prosthesis, we performed the operations with
mean crossclamp time of about 50 minutes. This pro-
cedure was much simpler as compared to aortic annulus
enlargement and implantation of stentless bioprothesis
valve. Further, no operation related death or serious
postoperative complications were presented in our study.
Furthermore, the heart function of all patients (LVEF
and LVFS) at one year after operation improved with left
ventricular mass regression and decrease of aortic trans-
valvular pressure gradient. It suggests that using small
Regent valve be an alternate choice for cardiac surgeons
when facing patients with small aortic annulus.
In our present study, 2 PPMs were documented in our
group 1. In our present study, the incidence of PPM is
relatively low (only 11% in group-1 and 0% in group-2).
According to the information of St Jude Company, the
17 mm Regent valve is suitable for patients with BSA
<1.7 m2, and 19 mm Regent valve is suitable for patients
with BSA < 1.9 m2. In our study, the BSA of the two
groups was 1.61 ± 0.26 m2. Actually, the BSA in group 1
(17 mm Regent) was 1.53 ± 0.12 m2 (data not shown).
That is perhaps the main reason for our low PPM inci-
dence. Besides, Dr. Minardi G, and Sezai A also showed
similar low incidence of PPM to our study (10.5% and
10.3%,respectively) [12,23]. Fortunately, as for these two
patients, the presence of PPM did not affect early and 3-
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a significant reduction of aortic transvalvular pressure
gradient occurred in both patients. It might be attributed
to that the EOA of the two patients (0.77 cm2/m2 and
0.83 cm2/m2) were little smaller than 0.85 cm2/m2. The
long-term follow-up needs to be carefully monitored.
Conclusion
In conclusion, for patients with small aortic annulus and
body surface area, implantation of SJM Regent bileaflet
prostheses would bring along heart function improvement
and clinical satisfaction of the patients, and would be a
better choice as compared to aortic annulus enlargement.
Consent
Written informed consent was obtained from the patient
for publication of this report and any accompanying
images.
Competing interests
The authors declare that they have no competing interests.
Authors’contributions
DZ, CG and CSW designed the study. DZ, TH collected the clinical data. CZP
performed the echocardiography. DZ drafted the manuscript. CG and CSW
did the revision. All authors read and approved the final manuscript.
Author details
1Department of Cardiac Surgery, Zhongshan Hospital Fudan University &
Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, People's
Republic of China. 2Department of Echocardiograph, Shanghai Institute of
Cardiovascular Diseases, Shanghai 200032, People’s Republic of China.
Received: 16 May 2012 Accepted: 17 September 2012
Published: 21 September 2012
References
1. Rahimtoola SH: The problem of valve prosthesis-patient mismatch.
Circulation 1978, 58(1):20.
2. Castro LJ, Arcidi JM Jr, Fisher AL, Gaudiani VA: Routine enlargement of the
small aortic root: a preventive strategy to minimize mismatch.
Ann Thorac Surg 2002, 74:31–36.
3. Emery RW: St Jude Medical Regent valve. J Thorac Cardiovasc Surg 2006,
131(3):760–761.
4. Sudkamp M, Lercher AJ, Muller-Riemenschneider F, et al: Transvalvular
in vivo gradients of the new generation bileaflet heart valve prosthesis
St. Jude Medical Regent in aortic position. Thorac Cardiovasc Surg 2003,
51(3):126–129.
5. Gelsomino S, Morocutti G, Da Col P, et al: Preliminary experience with the
St. Jude Medical Regent mechanical heart valve in the aortic position: early
in vivo hemodynamic results. Ann Thorac Surg 2002, 73(6):1830–1836.
discussion 1836.
6. Pibarot P, Dumesnil JG: Hemodynamic and clinical impact of prosthesis-
patient mismatch in the aortic valve position and its prevention.
J Am Coll Cardiol 2000, 36:1131.
7. Ellis JT, Yoganathan AP: A comparison of the hinge and near-hinge flow
fields of the St Jude medical hemodynamic plus and regent bileaflet
mechanical heart valves. J Thorac Cardiovasc Surg 2000, 119(1):83–93.
8. Tzikas A, Piazza N, Geleijnse ML, et al: Prosthesis-patient mismatch after
transcatheter aortic valve implantation with the Medtronic corevalve
system in patients with aortic stenosis. Am J Cardiol 2010, 106:255–260.
9. Yoshikawa K, Fukunaga S, Arinaga K, et al: Long-term results of aortic valve
replacement with a small St.Jude medical valve in Japanese patients.
Ann Thorac Surg 2008, 85:1303–1309.10. Moon MR, Pasque MK, Munfakh NA, et al: Prosthesis-patient mismatch
after aortic valve replacement:impact of age and body size on late
survival. Ann Thorac Surg 2006, 81:481–489.
11. Okamura H, Yamaguchi A, et al: The 17-mm St. Jude Medical Regent valve
is a valid option for patients with a small aortic annulus. Ann Thorac Surg
2009, 87(1):90–94.
12. Sezai A, Kasamaki Y, Abe K, et al: Assessment of the St. Jude Medical
Regent prosthetic valve by continuous-wave Doppler and dobutamine
stress echocardiography. Ann Thorac Surg 2010, 89(1):87–92.
13. Lam BK, Chan V, Hendry P, et al: The impact of patient-prosthesis
mismatch on late outcomes after mitral valve replacement.
J Thorac Cardiovasc Surg 2007, 133(6):1464–1473. Epub 2007 Apr 27.
14. Peterson MD, Borger MA, Feindel CM, et al: Aortic annular enlargement
during aortic valve replacement: improving results with time.
Ann Thorac Surg 2007, 83(6):2044–2049.
15. Bakhtiary F, Schiemann M, Dzemali O, et al: Impact of patient-prosthesis
mismatch and aortic valve design on coronary flow reserve after aortic
valve replacement. J Am Coll Cardiol 2007, 49(7):790–796. Epub 2007 Feb 5.
16. Howell NY, Keogh BE, Barnet V, et al: Patient-prosthesis mismatch does
not affect survival following aortic valve replacement. Eur J Cardiothorac
Surg 2006, 30(1):10–14. Epub 2006 May 24.
17. Sawant D, Singh AK, Feng WC, et al: Nineteen-millimeter aortic St.Jude
medical heart valve prosthesis:up to sixteen years' follow-up.
Ann Thorac Surg 1997, 63:964–970.
18. Botzenhardt F, Eichinger WB, Bleiziffer S, et al: Hemodynamic comparison
of bioprostheses for complete supra-annular position in patients with
small aortic annulus. J Am Coll Cardiol 2005, 45:2054–2060.
19. Takaseya T, Kawara T, Tokunaga S, et al: Aortic valve replacement with
17-mm St.Jude medical prostheses for a small aortic root in elderly
patients. Ann Thorac Surg 2007, 83:2050–2053.
20. Doss M, Martens S, Wood JP, et al: Performance of stentless versus
stented aortic valve bioprostheses in the elderly patient: a prospective
randomized trial. Eur J Cardiothorac Surg 2003, 23:299–304.
21. Kon ND, Cordell AR, Adair SM, et al: Aortic root replacement with the
freestyle stentless porcine aortic root bioprosthesis. Ann Thorac Surg
1999, 67:1609–1615.
22. Okumiya, Toshika IN, Mitsuko D, et al: Evaluation of intravascular
hemolysis with erythrocyte creatine in patients with cardiac valve
prostheses. Chest 2004, 1:13.
23. Minardi G, Manzara C, Creazzo V, et al: Evaluation of 17-mm St. Jude
Medical Regent prosthetic aortic heart valves by rest and dobutamine
stress echocardiography. J Cardiothorac Surg 2006, 1:27.
doi:10.1186/1749-8090-7-88
Cite this article as: Zhao et al.: Application of Regent mechanical valve
in patients with small aortic annulus: 3-year follow-up. Journal of
Cardiothoracic Surgery 2012 7:88.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
